Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

Abstract Alzheimer's disease (AD) staging criteria lack standardized, empirical description. Well‐defined AD staging criteria are an important consideration in protocol design, influencing a more standardized inclusion/exclusion criteria and defining what constitutes meaningful differentiation...

Full description

Bibliographic Details

Published in:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Main Authors:	Ronald C. Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee M. Sink, Maria C. Carrillo, Christopher J. Weber
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Subjects:	Alzheimer's disease amyloid biomarkers clinical trials cognition cognitive impairment
Online Access:	https://doi.org/10.1002/trc2.12434